Search by Drug Name or NDC

    NDC 54288-0142-10 PAPAVERINE HYDROCHLORIDE 30 mg/mL Details

    PAPAVERINE HYDROCHLORIDE 30 mg/mL

    PAPAVERINE HYDROCHLORIDE is a INTRAMUSCULAR; INTRAVENOUS; PARENTERAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by BPI Labs LLC. The primary component is PAPAVERINE HYDROCHLORIDE.

    Product Information

    NDC 54288-0142
    Product ID 54288-142_aff11037-bc62-4580-93b2-7ec748fbbef2
    Associated GPIs 40100060102005
    GCN Sequence Number 000527
    GCN Sequence Number Description papaverine HCl VIAL 30 MG/ML INJECTION
    HIC3 A7C
    HIC3 Description VASODILATORS,PERIPHERAL
    GCN 02100
    HICL Sequence Number 000170
    HICL Sequence Number Description PAPAVERINE HCL
    Brand/Generic Generic
    Proprietary Name PAPAVERINE HYDROCHLORIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Papaverine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS; PARENTERAL
    Active Ingredient Strength 30
    Active Ingredient Units mg/mL
    Substance Name PAPAVERINE HYDROCHLORIDE
    Labeler Name BPI Labs LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category UNAPPROVED DRUG OTHER
    Application Number n/a
    Listing Certified Through 2024-12-31

    Package

    NDC 54288-0142-10 (54288014210)

    NDC Package Code 54288-142-10
    Billing NDC 54288014210
    Package 10 VIAL in 1 CARTON (54288-142-10) / 2 mL in 1 VIAL (54288-142-01)
    Marketing Start Date 2021-07-10
    NDC Exclude Flag N
    Pricing Information N/A